Influence of advocacy groups, ALGS families on drug development highlighted at conference
During presentations at the 10th International Symposium & Scientific Meeting on Alagille Syndrome, Pam Vig, PhD, Head of Research & Development at Mirum Pharmaceuticals, Inc and Christine Clemson, PhD, Senior Vice President, Global Head Medical Affairs at Albireo Pharma, Inc highlighted the dedication their respective companies have to developing treatment...
Read MoreContact
© 2024 Med Journal 360™ is a trademark of International Healthcare Media, LLC. All rights Reserved